New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Domestic single-dose flu drug approved
- Water mahjong games cool visitors in Chongqing
- Sanya to host sixth Asian Beach Games in April
- Guangdong, Hong Kong and Macao to jointly hold entrepreneurship competition
- China approves rice-derived recombinant human albumin injection
- Hundreds attend 5th TCM Culture Festival in Tianjin
